MIT used AI to develop a new recipe for mRNA vaccines so they no longer need freezers and can sit at room temp for a full year or survive about 100F heat for 2 months.

This could finally let these vaccines reach poor countries without cold storage and even work as easy skin patches instead of shots.

AI replaced an exhaustive trial-and-error search, reaching a thermostable formulation in a few weeks instead of months.